Article

Isotretinoin use and subsequent depression and suicide: presenting the evidence.

Department of Medicine, Division of Dermatology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
American Journal of Clinical Dermatology (Impact Factor: 2.52). 02/2003; 4(7):493-505. DOI: 10.2165/00128071-200304070-00005
Source: PubMed

ABSTRACT The growing number of reported cases of depression and suicide associated with isotretinoin (a retinoid receptor agonist) use in patients with acne has prompted concern among dermatologists, patients, and their relatives and has triggered new warnings from regulators including depression-related, patient-informed consent forms. In establishing a cause-effect relationship, it is useful to judiciously consider whether there is an association, what is the nature of that association, if there is a plausible biological mechanism of action, the validity and reliability of measures used and the strength of study designs. Hoffmann-La Roche estimates that by April 2001 approximately 12 million patients worldwide have used isotretinoin, with 5 million patients in the US.A MEDLINE search between January 1966 and May 14 2003 of the published medical literature found 24 documented cases of isotretinoin-associated depression, with 3 suicides. One additional patient committed suicide during the fourth month of isotretinoin treatment and 3 further patients attempted suicide by taking an overdose of isotretinoin. The US FDA's Adverse Event Reporting System (AERS) contains almost 23,000 reports for isotretinoin from its approval in 1982 to December 2002. As of November 30, 2002, AERS contained 3,104 reports (US and foreign) with at least one reported psychiatric event. The FDA is aware of 173 reports of suicide (both US and foreign) in association with isotretinoin. Reports of positive dechallenge and rechallenge present a strong signal pointing to an association between isotretinoin and depression. A Hoffmann-La Roche sponsored epidemiological study failed to find any evidence of an association between isotretinoin and depression or suicide. However, the design of the study was flawed and the evidence was deemed inconclusive. Further studies using strong study designs, reliable and valid measures, and adequate sample sizes may bring us closer to the answer. The evidence suggesting a relationship between isotretinoin and depression needs to be weighed against the increasing prevalence of depression among adolescents and young adults and the psychological impact of acne. The literature contains credible evidence that isotretinoin treatment may reduce the psychosocial impact of acne in some patients. At the present time, there is no known pharmacological mechanism that would account for psychiatric symptomatology as a result of isotretinoin treatment; however, retinoid receptors are widely distributed in the brain and more research is needed to ascertain whether they have a role in depression. In the meantime, for the practitioner, the obvious benefit of isotretinoin in treating acne should encourage continued use. However, patients and their relatives must be informed and depressive symptoms should be actively assessed at each visit and, if necessary, referral to a psychiatrist, antidepressant therapy or discontinuation of isotretinoin should be considered.

1 Follower
 · 
116 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background and aims: Acne remains a severe problem for both patients and clinicians. Various approaches using photosurgery and phototherapy have been reported with varying degrees of success and robustness of results. An improved intense pulsed light (IPL) system has become available with interesting beam characteristic which might improve IPL treatment of inflammatory acne in the Asian skin, Fitzpatrick type III/IV. Subjects and Methods: The 18 study subjects comprised 15 females and 3 males with active mild to moderately severe inflammatory acne (mean age 25.3 ± 7.70 yr, range 17-47 yr, Burton scale 1-4, all Fitzpatrick type III Asian skin). They were treated once (8 subjects) or twice (10 subjects) with an IPL system offering both square pulse and time resolved spectral distribution technologies (420 nm cut-off filter, 30 ms pulse, 8 - 12 J/cm(2), 2-3 passes). Clinical photography was taken at baseline and at 4 weeks after the final treatment. Percentage of acne clearance was assessed by an independent dermatological panel and graded from zero to 5, 5 being total clearance. Results: All subjects completed the study. Post-treatment side effects were mild and transient, with virtually no downtime or postinflammatory hyperpigmentation (PIH) experienced by any subject. All subjects had some improvement and no exacerbation was seen in any subject. Clearance was evaluated by the panel as grade 4 in 5 subjects, grade 3 in 8, grade 2 in 4 and grade 1 in 1, so that 14 of 18 subjects (78%) had clearance of at least 60%. Patient evaluation was in general slightly better than that of the panel. Conclusions: The special beam characteristics of the IPL system used in the present preliminary study achieved good to very good results in the treatment of acne in the Fitzpatrick type III Asian skin without PIH induction. The results suggested that acne treatment in the Asian skin using this system is both safe and effective, and merits larger population studies to further optimize parameters and standardize top-up treatments.
    07/2012; 21(2):105-111. DOI:10.5978/islsm.12-OR-06
  • Source
    Revista de Psiquiatria Clínica 12/2011; 39(2):76-77. · 0.89 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: STRESZCZENIE Trądzik pospolity jest najczęstszą dermatozą wieku młodzieńczego, a jego rozpowszechnienie szacuje się w granicach od 35 do 90%. Jednym z najczęściej opisywanych zaburzeń psychicznych występujących u osób dotkniętych trądzikiem jest depresja. Niekwestionowanym przełomem w leczeniu trądziku okazało się wprowadzenie w latach 70. XX w. preparatów doustnej izotretynoiny, należącej do grupy retinoidów, wywołując jednocześnie ożywioną dyskusję na temat możliwości wywoływania przez nią zaburzeń psychicznych, zwłaszcza zaburzeń depresyjnych. Celem niniejszej pracy, opartej na analizie dostępnej literatury, była ocena związków między występowaniem trądziku, stosowaniem terapii przeciwtrądzikowej przy pomocy izotretynoiny a występowaniem zaburzeń depresyjnych. Praca została podzielona na 4części: w I przedstawiono definicję depresji, podając kryteria diagnostyczne oraz etiologię, w II omówiono rozpowszechnienie depresji w ogólnej populacji dzieci i młodzieży ze szczególnym uwzględnieniem rozpowszechnienia depresji u osób z trądzikiem, III stanowi przegląd prac dotyczących powiązań izotretynoiny z zaburzeniami nastroju, a IV zawiera podsumowanie doniesień i dyskusję. Bazując na dokonanym przeglądzie literatury oraz doświadczeniach własnych, autorzy tej pracy zwracają uwagę na dwa przeciwstawne działania izotretynoiny: przeciwdepresyjne i depresjogenne – w zależności od udziału poszczególnych czynników etiologicznych w wyzwalaniu i podtrzymaniu epizodu depresji. Autorzy podkreślają znaczenie oceny stanu psychicznego pacjenta przed włączeniem leku oraz w trakcie terapii izotretynoiną, z uwzględnieniem fizykalnych objawów depresji, zebranie dokładnego wywiadu w kierunku występowania zaburzeń psychicznych w przeszłości i w rodzinie pacjenta oraz ścisłą współpracę z lekarzem psychiatrą w przypadku jakichkolwiek wątpliwości dotyczących stanu psychicznego pacjenta. Autorzy postulują stworzenie polskiego konsensu dermatologiczno-psychiatrycznego w odniesieniu do terapii izotretynoiną na wzór powstałego w Australii. ABSTRACT Acne vulgaris is the most common dermatosis of adolescence with the prevalence ranging from 35% to 90%. The introduction of isotretinoin, a medicine belonging to retinoids, was in the 1970s an unquestionable breakthrough in the treatment of acne, while at the same time provoking heated debate over the possibility of psychiatric disorders as its possible side effect. Depression is one of the most frequently reported mental disorders that affect people suffering from acne. The aim of this paper, based on analysis of the available literature of the subject, was to evaluate relationships between acne, isotretinoin treatment for acne with and depressive disorder. The paper consists of four parts. Part I presents the definition of depression, its diagnostic criteria and etiology; part II shows the prevalence of depression in the general population of children and adolescents, with particular focus on the prevalence rate of depression in young people with acne; part III provides a literature review on associations between isotretinoin and mood disorders; and part IV contains summary of reported findings and
    Dermatologia Kliniczna 01/2014;